Viking Therapeutics, Inc. (VKTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Viking Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -11.02x | -39.90x | -20.44x | -10.49x | -6.46x | -10.35x |
| P/B Ratio | 6.20x | 4.98x | 5.04x | 4.97x | 1.76x | 1.67x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 9.33x | 33.09x | 19.19x | 7.61x | 23.98x | 21.11x |
| Quick Ratio | 9.33x | 33.09x | 19.19x | 7.61x | 23.98x | 21.11x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..